Nasomixin C.M. (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Nasomixin C.M., is a sympathomimetic (alpha‑adrenergic agonist) presented as a nasal formulation for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasomixin C.M. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets. Customers receive product traceability and support for pharmacovigilance.

Phenylephrine Hydrochloride is a topical alpha‑adrenergic decongestant that reduces nasal mucosal swelling.

- Nasal congestion due to common cold: reduces swelling of nasal mucosa, improving airflow. - Sinusitis-related congestion: alleviates blockage in sinus passages, facilitating drainage. - Allergic rhinitis: diminishes nasal edema caused by allergic inflammation, easing breathing. - Post‑nasal drip associated congestion: lessens mucosal swelling, helping to clear secretions.

Phenylephrine nasal administration may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of nasal mucosa - Headache - Rebound nasal congestion with prolonged use

Serious or Rare Side Effects: - Hypertension or marked increase in blood pressure - Cardiac arrhythmias or tachycardia - Severe allergic reaction (anaphylaxis) - Nasal septum perforation (rare with misuse)

When using Phenylephrine Hydrochloride nasal products, certain precautions should be observed to ensure safe and effective use.

- Contraindicated in patients with severe hypertension: avoid use or seek medical advice. - Use with caution in individuals taking monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Limit duration of use to no more than three consecutive days: prolonged use may cause rebound congestion. - Pregnant or breastfeeding women should consult a healthcare professional before use. - Children under a specified age should only use formulations approved for pediatric use. - Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Phenylephrine Hydrochloride can interact with other medicines, influencing its safety profile.

Major Interactions (Avoid): - MAO inhibitors (e.g., phenelzine, tranylcypromine): may cause severe hypertension. - Other sympathomimetic agents (e.g., pseudoephedrine, ephedrine): additive vasoconstrictive effect. - Certain antidepressants (e.g., tricyclics) that increase catecholamine levels: risk of hypertensive episodes.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs (e.g., beta‑blockers, ACE inhibitors): phenylephrine may reduce their efficacy. - Diuretics: may potentiate blood pressure changes. - Selective serotonin reuptake inhibitors (SSRIs): possible modest increase in blood pressure.